Teladoc pre-announces Q4 revenue $633-640M; FY22 revenue $2.403-2.410B

Teladoc Health, Inc.

2022-FY EPS reported -$84.60 revenue$2,406,840,000

FY2022 total revenue guided $2.403B-$2.410B, including ~$1B from BetterHelp.
Q4 2022 revenue expected $633M-$640M; adjusted EBITDA outlook unchanged from prior guidance.
Preliminary, unaudited figures subject to completion of financial close and audit.
Company reaffirms adjusted EBITDA outlook consistent with Q3 2022 earnings release.
Management to present at 41st Annual J.P. Morgan Healthcare Conference on Jan 9, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.